<DOC>
	<DOCNO>NCT03089112</DOCNO>
	<brief_summary>A Randomized , Open-label , Crossover Study Investigate Pharmacokinetic drug interaction Safety HGP1607 HGP1501 Healthy Male Volunteers</brief_summary>
	<brief_title>Pharmacokinetic Drug Interactions Between HGP1607 HGP1501</brief_title>
	<detailed_description />
	<criteria>1.age 19~40 year 2.The result BMI le 19 kg/m2 , 28 kg/m2 3.Subjects ability comprehend objective , content study property study drug participate trial willingness sign inform consent write 1 . Presence medical history concurrent disease may interfere treatment safety assessment completion clinical study , include clinically significant disorder digestive system , neuropsychiatric system , endocrine system , liver , cardiovascular system 2 . Subjects judge ineligible investigator</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>